Antiaging Quantum Living Sees Massive Revenue Surge Amid High Operating Losses in Recent Quarter

Company Overview: Antiaging Quantum Living Inc. (NASDAQ: ACHN) is an investment holding company primarily engaged in healthcare management and insurance services. Significant changes, including a change of control in 2023, reflect a pivot in business strategy towards acquiring companies in these sectors.

Latest Financial Performance:

• Revenue: - **Q3 (Three months ended December 31, 2024):** $154,471 - **Q3 (Three months ended December 31, 2023):** $6,299 - **% Change:** +2352.31%
• Net Loss: - **Q3 2024:** $129,154 - **Q3 2023:** $97,090 - **% Change:** +33.03%
• Operating Expenses: - **Q3 2024:** $348,125 - **Q3 2023:** $102,632 - **% Change:** +239.20%
• Loss from Operations: - **Q3 2024:** $(198,814) - **Q3 2023:** $(97,093)

Key Income Statement Highlights (Nine Months Ended December 31, 2024):

• Total Revenue: $529,714 (compared to $7,499 in 2023, a growth of 6963.80%)
• Total Operating Expenses: $1,120,531 (compared to $157,938 in 2023, increase of 604.48%)
• Total Net Loss: $(540,808) (vs $(151,196) in 2023, increase of 257.69%)

Positive Aspects:

• Significant increase in revenue, primarily driven by technical operation support and maintenance services.
• Improvement in cash position, ending with $202,487 as of December 31, 2024, up from $166,552.

Negative Aspects:

• Continued high operating losses; losses from operations increased materially.
• Accumulated deficit now stands at $1,230,111, raising concerns about long-term viability.

Liabilities and Going ConcernChallenges:

• Total liabilities increased to $2,522,013 (from $1,425,580), primarily due to new long-term notes payable.
• Operating cash flows remain negative, raising substantial doubt about the Company's ability to continue as a going concern.

Management's Strategy: The Company plans to improve its profitability and cash flow by pursuing business combinations and potentially raising capital from its majority shareholder.